OngoingEUCTR 2020-002196-35
This observational study is following people with Neurodevelopmental disorders Autism spectrum disorder Attention deficit hyperactivity disorder Learning disorders or Children, Adolescents, Under 18 to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Amsterdam UMC, location VUmc
- Condition
- ADHD
OngoingEUCTR 2012-000492-17
This study is looking at whether METHYLPHENIDATE HYDROCHLORIDE can help people with Attention-deficit hyperactivity disorder or Children, Adolescents, Under 18. Participants receive the study medicine METHYLPHENIDATE HYDROCHLORIDE and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam
- Condition
- ADHD
OngoingEUCTR 2009-012261-61
This study is looking at whether METHYLPHENIDATE can help people with ADHD with and without substance use disorder. Participants receive the study medicine METHYLPHENIDATE and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Academic Medical Center
- Condition
- ADHD
OngoingEUCTR 2007-004664-46
This study is comparing METHYLPHENIDATE with placebo for people with Sleep disorders in Attention-Deficit/ Hyperactivity Disorder or Children, Adolescents, Under 18. Participants receive METHYLPHENIDATE or placebo and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- No Sponsor
- Condition
- ADHD
OngoingEUCTR 2022-003237-19
This study is looking at whether Tentin can help people with Attention Deficit Hyperactivity Disorder. Participants receive the study medicine Tentin and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Amsterdam UMC
- Condition
- ADHD
OngoingEUCTR 2014-005045-53
This study is looking at whether METHYLPHENIDATE can help people with Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit. Participants receive the study medicine METHYLPHENIDATE and complete study visits and assessments.
ADHDOther
- Countries
- Sweden
- Sponsor
- Landstinget Västmanland
- Condition
- ADHD
OngoingEUCTR 2010-019930-28
This study is comparing Ritalin with placebo for people with Adhd odd or Children, Under 18. Participants receive Ritalin or placebo and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Accare
- Condition
- ADHD
OngoingEUCTR 2009-011887-12
This study is looking at whether Methylphenidate compared with Atomoxetine can help people with ADHD is a neurobehavioral developmental disorder which affects about 5% of children. In our clinical trial designed we would like to examine whether medical treatment with stimulants has an influen or Children, Adolescents, Under 18.
ADHDOther
- Countries
- Germany
- Sponsor
- Praxis Prof. Koenig
- Condition
- ADHD
OngoingEUCTR 2008-001291-71
This study is comparing Atomoxetinhydrochlorid with placebo for people with Attention-deficit hyperactivity disorder or Children, Adolescents, Under 18. Participants receive Atomoxetinhydrochlorid or placebo and complete study visits and assessments.
ADHDOther
- Countries
- Germany
- Sponsor
- University of Wuerzburg
- Condition
- ADHD
OngoingEUCTR 2013-004776-35
This study is looking at whether Methylphenidate can help people with Cardiovascular functioning in Attention deficit hyperactivity disorder following 3 years of treatment with methylphenidate or Adolescents, Under 18. Participants receive the study medicine Methylphenidate and complete study visits and assessments.
ADHDOther
- Countries
- United Kingdom
- Sponsor
- Radboud University Medical Centre Nijmegen
- Condition
- ADHD
OngoingEUCTR 2016-002474-13
This study is testing a medication approach for people with Attention Deficit Hyperactivity Disorder or Children, Adolescents, Under 18. Participants receive a study treatment and complete follow-up visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Innovatiefonds Zorgverzekeraars
- Condition
- ADHD
OngoingEUCTR 2017-001490-16
This study is looking at whether lisdexamfetamine dimesylate can help people with Bulimia Nervosa with and without simultaneous Attention Deficit Hyperactivity Disorder. Participants receive the study medicine lisdexamfetamine dimesylate and complete study visits and assessments.
ADHDOther
- Countries
- Sweden
- Sponsor
- Stockholms läns landsting
- Condition
- ADHD
OngoingEUCTR 2010-020508-31
This study is looking at whether Medikinet CR, 10, 20, 30 en 40 mg, capsules met verlengde afgifte, hard. can help people with Attention Deficit Hyperactivty Disoerder or Children, Adolescents, Under 18.
ADHDOther
- Countries
- Netherlands
- Sponsor
- ZonMw zorg voor jeugd-effecten en kosten
- Condition
- ADHD
OngoingEUCTR 2007-001855-20
This study is comparing Atomoxetine hydrochloride with placebo for people with The effects of atomoxetine on driving performance, attention and response inbihition are studied in with attention-deficit hyperactivity disorder. Participants receive Atomoxetine hydrochloride or placebo and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Faculty of Social Sciences, Utrecht University
- Condition
- ADHD
OngoingEUCTR 2016-002875-81
This study is looking at whether Bumetanide can help people with Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Epilepsy or Children, Adolescents, Under 18. Participants receive the study medicine Bumetanide and complete study visits and assessments.
ADHDOther
- Countries
- Netherlands
- Sponsor
- UMC Utrecht
- Condition
- ADHD
CompletedNCT05206734
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 5 Years to 25 Years
- Countries
- United Kingdom
- Sponsor
- Momentum Data
- Condition
- Depression
TerminatedNCT01506232
This study exists to understand what helps questionnaires and follow-up reports work in everyday practice, not just under ideal conditions. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- ADHD
CompletedNCT01931644
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
ADHDOtherFrom 18 Years to 100 Years
- Countries
- United States
- Sponsor
- Sanguine Biosciences
- Condition
- ADHD
CompletedNCT02478788
This study exists to see whether the medication Risk can play a useful role in care. Researchers are trying to understand whether the medication Risk can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 10 Years to 18 Years
- Countries
- United States
- Sponsor
- University of Cincinnati
- Condition
- Bipolarity
CompletedNCT05601063
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 14 Years to 50 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
WithdrawnNCT03842345
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.
DepressionOtherOver 18 Years
- Countries
- Global
- Sponsor
- QuantalX Neuroscience
- Condition
- Depression
CompletedNCT00794040
This study exists to see whether the medication Serotonin can play a useful role in care. Researchers are trying to understand whether the medication Serotonin can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 7 Years to 17 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- ADHD
CompletedNCT03292848
This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT00399698
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 4 Years to 14 Years
- Countries
- United States
- Sponsor
- Ohio State University
- Condition
- ADHD
Not Yet RecruitingNCT07540585
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 100 Years
- Countries
- United States
- Sponsor
- Indiana University
- Condition
- Depression